| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |